Information  X 
Enter a valid email address

Accrol Group Hldgs (ACRL)

  Print   

Wednesday 29 January, 2020

Accrol Group Hldgs

Director's Dealing

RNS Number : 2216B
Accrol Group Holdings PLC
29 January 2020
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

29 January 2020

                                                                              Accrol Group Holdings plc

(AIM: ACRL) 

 

Director's Dealing

 

Accrol Group Holdings plc (the "Company" or "Accrol"), the AIM-listed leading independent tissue converter, announces that, Dan Wright, Executive Chairman of Accrol purchased 1,000,000 ordinary shares of £0.001 each ("Ordinary Shares") on 28 January 2020 at a price of 38.0p per Ordinary Share. Following this purchase, he now holds 4,077,808 Ordinary Shares representing 2.09% of the current Issued Share Capital of the Company.

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Dan Wright

 

2

Reason for the notification

a)

Position/status

Executive Chairman

 

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Accrol Group Holdings plc

b)

LEI

213800MC56M5G69RJ226

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.001

 

ISIN: GB00BZ6VT592

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

38.0p

 

Volume(s)

1,000,000

 

d)

Aggregated information

- Aggregated volume

- Price


N/A - single transaction

e)

Date of the transaction

28 January 2020

f)

Place of the transaction

London Stock Exchange, AIM

 

 

Enquiries:

 

 

For further information, please contact:

 

 

 

Accrol Group Holdings plc

 

Dan Wright, Executive Chairman

+44 (0) 1254 278 844

Gareth Jenkins, Chief Executive Officer

+44 (0) 1254 278 844

 

 

Zeus Capital Limited (Nominated Adviser & Broker) 

 

Dan Bate / Nick Cowles

+44 (0) 161 831 1512

Dominic King / John Goold

+44 (0) 203 829 5000

 

 

Belvedere Communications Limited

 

Cat Valentine ([email protected])

+44 (0) 7715 769 078

Keeley Clarke ([email protected])


+44 (0) 7967 816 525

Llew Angus ([email protected])

+44 (0) 7407 023 147

 

 

Notes to Editors

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK. 

 

The business operates from four sites in Lancashire:

·

A manufacturing, storage and distribution facility in Blackburn;

·

A storage and administrative centre in Blackburn;

·

A facial tissue plant, also in Blackburn; and

·

A manufacturing, storage and distribution facility in Leyland.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHBCGDBUDDDGGI

a d v e r t i s e m e n t